Metvian PG 2mg/500mg/15mg Tablet SR
Marketer
Vivichem Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metvian PG 2mg/500mg/15mg Tablet SR
GlycoBalance TR 2mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This regimen, used alongside diet and exercise, enhances blood sugar control in adult type 2 diabetics. It promotes efficient insulin use, thus reducing blood sugar. Follow your physician's prescribed dosage and schedule for GlycoBalance TR 2mg/500mg/15mg Extended-Release Tablets; administer with food to prevent digestive discomfort. If a dose is missed, take it promptly, unless the next dose is imminent; avoid doubling the dose. Excessive intake risks hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol, or skipped meals may cause hypoglycemia; regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Consult your doctor about pre-existing kidney, liver, or heart conditions before starting treatment. Pregnant or breastfeeding individuals should seek medical advice. Kidney function tests will be performed prior to treatment commencement. Limit alcohol consumption as it can heighten the risk of adverse effects.
Uses of Metvian PG 2mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Metvian PG 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Metvian PG 2mg/500mg/15mg sustained-release tablet with a meal.
Common Side effects of Metvian PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metvian PG 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metvian PG 2mg/500mg/15mg Extended-Release Tablets with food.
How Metvian PG 2mg/500mg/15mg Tablet SR works:
Metvian PG 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to enhance blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and boosting insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Metvian PG 2mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Metvian PG 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Metvian PG 2mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Metvian PG 2mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Metvian PG 2mg/500mg/15mg SR tablets. Physician consultation is recommended. Routine assessment of kidney function is advised during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Metvian PG 2mg/500mg/15mg SR tablets, as dose modification may be necessary. Individuals with severe hepatic dysfunction should avoid this medication. A physician's consultation is advised.
What if you forget to take Metvian PG 2mg/500mg/15mg Tablet SR :
Should you forget a Metvian PG 2mg/500mg/15mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metvian PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently